Delivery Order SPE2DR25D1100-SPE2DR26FCR2E
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,372.56 to AmerisourceBergen Drug Corp for the procurement of Bicillin L-A 2,400,000 units in 4 mL formulation. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by November 14, 2025. The award was issued on November 13, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $2,795.08 to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 Units 2ML, a penicillin-based antibiotic product. The contract, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, utilizes firm fixed-price pricing and was competitively awarded without set-aside designation. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Bicillin L-A 1,200,000 Units 2ML, with a ceiling value of $5,709.85 and an ultimate completion date of June 2, 2025. This delivery order was competitively awarded with no set-aside designation and represents a procurement under the company's broader pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $66,459.20 to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ml formulations. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be completed by November 5, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Bicillin L-A 2,400,000 units in 4 milliliter formulations. This is a firm fixed-price delivery order with a ceiling value of $2,732.81 and an ultimate completion date of October 24, 2025. The award was made on a competitive basis with no set-aside designation, and the product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $34,644.96 to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 units in 2ML vials. This firm fixed price delivery order, issued on May 7, 2025, represents a competitive award with no set-aside designation and carries an ultimate completion date of May 8, 2025. The contract is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bicillin L-A 1,200,000 units (2mL formulation) valued at $6,904.59. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Bicillin L-A 2,400,000 units in 4ml formulations, with a ceiling value of $2,822.76. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for ultimate completion by September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a $51,829.08 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,200,000 units of Bicillin L-A, a prescription antibiotic medication. The award has an ultimate completion date of September 4, 2024 and is not set aside. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Bicillin L-A 1,200,000 units in 2ml formulations, with a ceiling value of $14,887.08. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCR2EDelivery Order
The Defense Logistics Agency awarded a $5,590.16 delivery order to AmerisourceBergen Drug Corp for the supply of Bicillin L-A 1,200,000 Units 2ML, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed price contract contains no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing $999,999,999.00 indefinite delivery vehicle with the Defense Logistics Agency, designated SPE2DX and active through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies comprehensive pharmaceutical products and medical commodities to support military and veteran healthcare systems. The company's portfolio with DLA encompasses a broad range of medications, vaccines, and specialized medical supplies across multiple therapeutic domains, reflecting its established capability to meet federal procurement requirements through open competition. Bicillin L-A is a penicillin-based antibiotic commonly used in military medical supply chains for treating bacterial infections.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 11/23/25 |